Gilead Sciences, Inc. (GILD) operating KPIs
GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.68+5.07 (+3.06%)
Close on Oct 30, 2026Market cap $211.64BP/E –Yield 1.85%
Gilead Sciences net income (loss) attributable to Gilead ($M) ($M)
Form 10-Q / 10-K (DB)
Latest, Q2 2026
-10,496
Period ended Jun 30, 2026
Change on a year earlier
-635.5%
1,960 in Q2 2025
History
71 quarters
Since Q2 2008
Sources
56
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Net income (loss) attributable to Gilead ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | -10,496 | -635.5% | Form 10-Q (filed 2026-08-06) ↗ |
| Q1 2026 | Mar 31, 2026 | 2,021 | +53.7% | Form 10-Q (filed 2026-05-07) ↗ |
| Q4 2025 | Dec 31, 2025 | 2,183 | +22.4% | Form 10-K (filed 2026-02-24) ↗ |
| Q3 2025 | Sep 30, 2025 | 3,052 | +143.6% | Form 10-Q (filed 2025-11-07) ↗ |
| Q2 2025 | Jun 30, 2025 | 1,960 | +21.4% | Form 10-Q (filed 2025-08-07) ↗ |
| Q1 2025 | Mar 31, 2025 | 1,315 | -131.5% | Form 10-Q (filed 2025-05-07) ↗ |
| Q4 2024 | Dec 31, 2024 | 1,783 | +24.8% | Form 10-K (filed 2025-02-28) ↗ |
| Q3 2024 | Sep 30, 2024 | 1,253 | -42.5% | Form 10-Q (filed 2024-11-12) ↗ |
| Q2 2024 | Jun 30, 2024 | 1,614 | +54.4% | Form 10-Q (filed 2024-08-08) ↗ |
| Q1 2024 | Mar 31, 2024 | -4,170 | -512.9% | Form 10-Q (filed 2024-05-08) ↗ |
| Q4 2023 | Dec 31, 2023 | 1,429 | -12.9% | Form 10-K (filed 2024-02-23) ↗ |
| Q3 2023 | Sep 30, 2023 | 2,180 | +21.9% | Form 10-Q (filed 2023-11-07) ↗ |
| Q2 2023 | Jun 30, 2023 | 1,045 | -8.7% | Form 10-Q (filed 2023-08-04) ↗ |
| Q1 2023 | Mar 31, 2023 | 1,010 | +5,215.8% | Form 10-Q (filed 2023-05-03) ↗ |
| Q4 2022 | Dec 31, 2022 | 1,640 | +329.3% | Form 10-K (filed 2023-02-22) ↗ |
| Q3 2022 | Sep 30, 2022 | 1,789 | -31.0% | Form 10-Q (filed 2022-11-02) ↗ |
| Q2 2022 | Jun 30, 2022 | 1,144 | -24.8% | Form 10-Q (filed 2022-08-08) ↗ |
| Q1 2022 | Mar 31, 2022 | 19 | -98.9% | Form 10-Q (filed 2022-05-04) ↗ |
| Q4 2021 | Dec 31, 2021 | 382 | -75.4% | Form 10-K (filed 2022-02-23) ↗ |
| Q3 2021 | Sep 30, 2021 | 2,592 | +620.0% | Form 10-Q (filed 2021-11-03) ↗ |
| Q2 2021 | Jun 30, 2021 | 1,522 | -145.6% | Form 10-Q (filed 2021-08-05) ↗ |
| Q1 2021 | Mar 31, 2021 | 1,729 | +11.5% | Form 10-Q (filed 2021-05-06) ↗ |
| Q4 2020 | Dec 31, 2020 | 1,551 | -42.5% | Form 10-K (filed 2021-02-25) ↗ |
| Q3 2020 | Sep 30, 2020 | 360 | -130.9% | Form 10-Q (filed 2020-11-04) ↗ |
| Q2 2020 | Jun 30, 2020 | -3,339 | -277.6% | Form 10-Q (filed 2020-08-06) ↗ |
| Q1 2020 | Mar 31, 2020 | 1,551 | -21.5% | Form 10-Q (filed 2020-05-06) ↗ |
| Q4 2019 | Dec 31, 2019 | 2,696 | +89,766.7% | Form 10-K (filed 2020-02-25) ↗ |
| Q3 2019 | Sep 30, 2019 | -1,165 | -155.6% | Form 10-Q (filed 2019-11-05) ↗ |
| Q2 2019 | Jun 30, 2019 | 1,880 | +3.5% | Form 10-Q (filed 2019-08-06) ↗ |
| Q1 2019 | Mar 31, 2019 | 1,975 | +28.4% | Form 10-Q (filed 2019-05-08) ↗ |
| Q4 2018 | Dec 31, 2018 | 3 | -100.1% | Form 10-K (filed 2019-02-26) ↗ |
| Q3 2018 | Sep 30, 2018 | 2,097 | -22.8% | Form 10-Q (filed 2018-11-06) ↗ |
| Q2 2018 | Jun 30, 2018 | 1,817 | -40.9% | Form 10-Q (filed 2018-08-06) ↗ |
| Q1 2018 | Mar 31, 2018 | 1,538 | -43.1% | Form 10-Q (filed 2018-05-09) ↗ |
| Q4 2017 | Dec 31, 2017 | -3,865 | -224.4% | Form 10-K (filed 2018-02-27) ↗ |
| Q3 2017 | Sep 30, 2017 | 2,718 | -18.4% | Form 10-Q (filed 2017-11-07) ↗ |
| Q2 2017 | Jun 30, 2017 | 3,073 | -12.1% | Form 10-Q (filed 2017-08-07) ↗ |
| Q1 2017 | Mar 31, 2017 | 2,702 | -24.2% | Form 10-Q (filed 2017-05-10) ↗ |
| Q4 2016 | Dec 31, 2016 | 3,108 | -33.6% | Form 10-K (filed 2017-02-27) ↗ |
| Q3 2016 | Sep 30, 2016 | 3,330 | -27.6% | Form 10-Q (filed 2016-11-07) ↗ |
| Q2 2016 | Jun 30, 2016 | 3,497 | -22.2% | Form 10-Q (filed 2016-08-05) ↗ |
| Q1 2016 | Mar 31, 2016 | 3,566 | -17.7% | Form 10-Q (filed 2016-05-06) ↗ |
| Q4 2015 | Dec 31, 2015 | 4,683 | +34.3% | Form 10-K (filed 2016-02-24) ↗ |
| Q3 2015 | Sep 30, 2015 | 4,600 | +68.4% | Form 10-Q (filed 2015-11-04) ↗ |
| Q2 2015 | Jun 30, 2015 | 4,492 | +22.9% | Form 10-Q (filed 2015-08-05) ↗ |
| Q1 2015 | Mar 31, 2015 | 4,333 | +94.6% | Form 10-Q (filed 2015-05-08) ↗ |
| Q4 2014 | Dec 31, 2014 | 3,487 | +340.8% | Form 10-K (filed 2015-02-25) ↗ |
| Q3 2014 | Sep 30, 2014 | 2,731 | +246.1% | Form 10-K (filed 2015-02-25) ↗ |
| Q2 2014 | Jun 30, 2014 | 3,656 | +373.0% | Form 10-K (filed 2015-02-25) ↗ |
| Q1 2014 | Mar 31, 2014 | 2,227 | +208.4% | Form 10-K (filed 2015-02-25) ↗ |
| Q4 2013 | Dec 31, 2013 | 791 | +3.7% | Form 10-K (filed 2015-02-25) ↗ |
| Q3 2013 | Sep 30, 2013 | 789 | +16.8% | Form 10-K (filed 2015-02-25) ↗ |
| Q2 2013 | Jun 30, 2013 | 773 | +8.6% | Form 10-K (filed 2015-02-25) ↗ |
| Q1 2013 | Mar 31, 2013 | 722 | +63.3% | Form 10-K (filed 2015-02-25) ↗ |
| Q4 2012 | Dec 31, 2012 | 763 | +14.6% | Form 10-K (filed 2013-02-27) ↗ |
| Q3 2012 | Sep 30, 2012 | 676 | +52.8% | Form 10-Q (filed 2012-11-06) ↗ |
| Q2 2012 | Jun 30, 2012 | 712 | -4.6% | Form 10-K (filed 2013-02-27) ↗ |
| Q1 2012 | Mar 31, 2012 | 442 | -32.1% | Form 10-K (filed 2013-02-27) ↗ |
| Q4 2011 | Dec 31, 2011 | 665 | +5.7% | Form 10-K (filed 2012-02-23) ↗ |
| Q3 2011 | Sep 30, 2011 | 442 | – | Form 10-Q (filed 2013-05-08) ↗ |
| Q2 2011 | Jun 30, 2011 | 746 | – | Form 10-K (filed 2013-02-27) ↗ |
| Q1 2011 | Mar 31, 2011 | 651 | -23.8% | Form 10-K (filed 2013-02-27) ↗ |
| Q4 2010 | Dec 31, 2010 | 629 | -21.5% | Form 10-K (filed 2011-02-28) ↗ |
| Q1 2010 | Mar 31, 2010 | 855 | +45.1% | Form 10-Q (filed 2010-05-10) ↗ |
| Q4 2009 | Dec 31, 2009 | 802 | +43.3% | Form 10-K (filed 2011-02-28) ↗ |
| Q3 2009 | Sep 30, 2009 | 673 | +35.7% | Form 10-Q (filed 2009-11-05) ↗ |
| Q2 2009 | Jun 30, 2009 | 571 | +31.4% | Form 10-Q (filed 2009-08-05) ↗ |
| Q1 2009 | Mar 31, 2009 | 589 | – | Form 10-Q (filed 2010-05-10) ↗ |
| Q4 2008 | Dec 31, 2008 | 560 | – | Form 10-K (filed 2010-03-01) ↗ |
| Q3 2008 | Sep 30, 2008 | 496 | – | Form 10-Q (filed 2009-11-05) ↗ |
| Q2 2008 | Jun 30, 2008 | 435 | – | Form 10-Q (filed 2009-08-05) ↗ |
Cite this data
StockData. (2026). Gilead Sciences Net income (loss) attributable to Gilead ($M) ($M), quarterly Q2 2008–Q2 2026 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/fs_netinc
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.